Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 2,528 | 3,545 | 5,379 | 4,534 | 4,025 |
| Operating Income | -2,528 | -3,545 | -5,379 | -4,534 | -4,025 |
| Interest Expense | 5 | 7 | 7 | -2 | 4 |
| Other Income | 2 | 7 | 11 | 9 | 8 |
| Pre-tax Income | -2,531 | -3,545 | -5,375 | -4,523 | -4,021 |
| Net Income Continuous | -2,531 | -3,545 | -5,375 | -4,523 | -4,021 |
| Net Income | $-2,531 | $-3,545 | $-5,375 | $-4,523 | $-4,021 |
| EPS Basic Total Ops | -4,049.20 | -12,250.66 | -8,812.85 | -32,497.00 | -31,128.45 |
| EPS Basic Continuous Ops | -2,530.75 | -14,184.67 | 27,769.71 | -32,318.61 | -30,944.95 |
| EPS Diluted Total Ops | -4,049.20 | -12,250.66 | -8,812.85 | -32,497.00 | -31,128.45 |
| EPS Diluted Continuous Ops | -2,530.75 | -14,184.67 | 27,494.48 | -32,318.61 | -30,669.71 |
| EPS Diluted Before Non-Recurring Items | -4,033.61 | -12,304.92 | -28,511.40 | N/A | N/A |
| EBITDA(a) | $-2,527 | $-3,544 | $-5,378 | $-4,533 | $-4,024 |